Message from the Chief
Patient Documentary
Rock musician Pat Spurgeon recounts his battle with kidney failure and treatment by UCSF transplant surgeon Sang-Mo Kang in a recent documentary.
Transplant Video Library
View videos of lectures pertaining to transplantation given by some of the world's top experts on the subject.
Make a Gift
A gift to the Department of Surgery helps us discover new treatments and cures.
Flavio Vincenti, M.D.
Clinical Professor of Medicine and Surgery
Department of Medicine, Division of Nephology
Department of Surgery, Division of Transplant Surgery
Contact Information
505 Parnassus Ave, Moffitt 884
San Francisco, CA 94143-0780
Phone: 415.353.1322
Fax: 415.353.8974
Flavio.Vincenti@ucsfmedctr.org
Education
- American University Medical Center of Beirut, BS - 1971
- Universite Saint-Joseph Faculty of Medicine, MD - 1975
Residencies
- Internal Medicine Residency: American University of Beirut Medical Center
Fellowships
- Fellow in Nephrology, Emory University School of Medicine, Atlanta, Georgia, July 1, 1973 - June 30, 1975
- Research Fellow, National Kidney Foundation, July 1, 1974 - June 30, 1975
- Fellow in Cardiovascular Research Institute (Nephrology) University of California, San Francisco, July 1, 1975 - June 30, 1976
Board Certification
American Board of Internal Medicine, Internal Medicine; Nephrology - Subspecialty
Clinical Expertise
- Internal Medicine
- Transplant Nephrology
- Kidney And Pancreas Transplant
Research Interests
- Transplant Nephrology
Biography
Dr. Flavio Vincenti, a kidney and pancreas transplant specialist, is board certified in internal medicine and nephrology. He came to UCSF Medical Center in 1975 for a transplant nephrology fellowship and was appointed a member of the kidney transplant team.
His memberships in professional organizations include the American Society of Nephrology, American Society of Transplantation, International Society of Nephrology and Transplantation Society. He is a co-leader of the kidney section of the Immune Tolerance Network for kidney transplantation. In addition, he is on the editorial board of the American Journal of Kidney Diseases and Graft.
In 1978, Vincenti was one of the authors of an article in the New England Journal of Medicine about the role of blood transfusions in improving kidney transplants. He also wrote a series of articles on the complications of transplants and has been a leading investigator and author on the use of anti interleukin 2 receptor monoclonal antibodies. In addition, he is a proponent of minimizing immunosuppressive drugs after transplants.
Selected Publications
- Hirose R, Vincenti F. Review of transplantation--1999. Clin Transpl. 1999;:295-315. Review.
- Norman DJ, Vincenti F, de Mattos AM, Barry JM, Levitt DJ, Wedel NI, Maia M, Light SE. Phase I trial of HuM291, a humanized anti-CD3 antibody, in patients receiving renal allografts from living donors. Transplantation. 2000 Dec 27;70(12):1707-12.
- Korsun A, Vincenti F, Ruck D, Whitelaw N, Ladoulis C, Whitelaw G. The role of daclizumab in balancing resources for inpatient and outpatient transplant services. Prog Transplant. 2000 Mar;10(1):21-4. Review.
- Ekberg H, Backman L, Tufveson G, Tyden G, Nashan B, Vincenti F. Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis. Transpl Int. 2000;13(2):151-9.
- Pirsch J, Bekersky I, Vincenti F, Boswell G, Woodle ES, Alak A, Kruelle M, Fass N, Facklam D, Mekki Q. Coadministration of tacrolimus and mycophenolate mofetil in stable kidney transplant patients: pharmacokinetics and tolerability. J Clin Pharmacol. 2000 May;40(5):527-32.
